SCHEMBL1974209

SCHEMBL1974209

Cc1ccc(Cl)cc1NC(=O)c1ccc2[nH]c(Nc3c(Cl)cccc3Cl)nc2c1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 2/20 0.50
NPC1 O15118 3/20 0.48
RAB9A P51151 3/20 0.48
MEN1 O00255 1/20 0.48
KMT2A Q03164 1/20 0.48
SMN1; SMN2 Q16637 4/20 0.46
MAPT P10636 5/20 0.44
TP53 P04637 2/20 0.44
IRAK4 Q9NWZ3 2/20 0.43
PTGES O14684 1/20 0.43
LMNA P02545 3/20 0.42
POLB P06746 3/20 0.42
KDM4E B2RXH2 1/20 0.42
NPY1R P25929 1/20 0.42
HTT P42858 1/20 0.42
NPY2R P49146 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
DGAT1 O75907 1/20 0.42
JAK2 O60674 1/20 0.41
JAK1 P23458 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16363593 0.91 KMT2A (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL13393449 0.90 MAPT (0.50) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL1973509 0.87 MAPT (0.55) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL16364384 0.86 NPC1 (0.54) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL16363568 0.85 MAPT (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL16364381 0.85 NPC1 (0.49) NPC1RAB9AMEN1KMT2AMAPT
SCHEMBL1973147 0.85 IRAK4 (0.58) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL13392916 0.84 SORT1 (0.45) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL13393490 0.83 NPC1 (0.51) NPC1RAB9AMEN1KMT2ASMN1; SMN2
SCHEMBL1975192 0.83 NPC1 (0.46) NPC1RAB9AMEN1KMT2ASMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8916599-B2 1H-benz imidazole-5-carboxamides as anti-inflammatory agents OREXO AB (SE) 2014-12-23 US disclosed
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2011-12-22 US disclosed
EP-2334652-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS Boehringer Ingelheim International GmbH (DE) 2011-06-22 EP disclosed
WO-2010034796-A1 1H-BENZ IMIDAZOLE-5-CARBOXAMIDES AS ANTI-INFLAMMATORY AGENTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-04-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110312935-A1 1H-Benz Imidazole-5-Carboxamides As Anti-Inflammatory Agents MAPRE2, MAPRE1, H1-4 GAA 2503/4885NPC1 4650/4885RAB9A 867/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.